178 related articles for article (PubMed ID: 38734692)
1. Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways.
Park JC; Kim YJ; Hwang GH; Kang CY; Bae S; Cha HJ
Nat Commun; 2024 May; 15(1):4002. PubMed ID: 38734692
[TBL] [Abstract][Full Text] [Related]
2. Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells.
Li M; Zhong A; Wu Y; Sidharta M; Beaury M; Zhao X; Studer L; Zhou T
Nat Commun; 2022 Oct; 13(1):6354. PubMed ID: 36302757
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
4. Prime Editing and DNA Repair System: Balancing Efficiency with Safety.
Daliri K; Hescheler J; Pfannkuche KP
Cells; 2024 May; 13(10):. PubMed ID: 38786078
[TBL] [Abstract][Full Text] [Related]
5. High expression of uracil DNA glycosylase determines C to T substitution in human pluripotent stem cells.
Park JC; Jang HK; Kim J; Han JH; Jung Y; Kim K; Bae S; Cha HJ
Mol Ther Nucleic Acids; 2022 Mar; 27():175-183. PubMed ID: 34976436
[TBL] [Abstract][Full Text] [Related]
6. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes.
Chen PJ; Hussmann JA; Yan J; Knipping F; Ravisankar P; Chen PF; Chen C; Nelson JW; Newby GA; Sahin M; Osborn MJ; Weissman JS; Adamson B; Liu DR
Cell; 2021 Oct; 184(22):5635-5652.e29. PubMed ID: 34653350
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of prime editing outcomes in human embryonic stem cells.
Habib O; Habib G; Hwang GH; Bae S
Nucleic Acids Res; 2022 Jan; 50(2):1187-1197. PubMed ID: 35018468
[TBL] [Abstract][Full Text] [Related]
8. Robust genome editing via modRNA-based Cas9 or base editor in human pluripotent stem cells.
Haideri T; Howells A; Jiang Y; Yang J; Bao X; Lian XL
Cell Rep Methods; 2022 Sep; 2(9):100290. PubMed ID: 36160051
[TBL] [Abstract][Full Text] [Related]
9. Development of an Efficient C-to-T Base-Editing System and Its Application to Cellulase Transcription Factor Precise Engineering in Thermophilic Fungus
Zhang C; Li N; Rao L; Li J; Liu Q; Tian C
Microbiol Spectr; 2022 Jun; 10(3):e0232121. PubMed ID: 35608343
[No Abstract] [Full Text] [Related]
10. Prime editing: advances and therapeutic applications.
Zhao Z; Shang P; Mohanraju P; Geijsen N
Trends Biotechnol; 2023 Aug; 41(8):1000-1012. PubMed ID: 37002157
[TBL] [Abstract][Full Text] [Related]
11. Gene editing with 'pencil' rather than 'scissors' in human pluripotent stem cells.
Park JC; Park MJ; Lee SY; Kim D; Kim KT; Jang HK; Cha HJ
Stem Cell Res Ther; 2023 Jun; 14(1):164. PubMed ID: 37340491
[TBL] [Abstract][Full Text] [Related]
12. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.
Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A
Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing.
Chadwick AC; Wang X; Musunuru K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1741-1747. PubMed ID: 28751571
[TBL] [Abstract][Full Text] [Related]
14. MutSĪ± and MutSĪ² as size-dependent cellular determinants for prime editing in human embryonic stem cells.
Park JC; Kim YJ; Han JH; Kim D; Park MJ; Kim J; Jang HK; Bae S; Cha HJ
Mol Ther Nucleic Acids; 2023 Jun; 32():914-922. PubMed ID: 37346976
[TBL] [Abstract][Full Text] [Related]
15. Transition Substitution of Desired Bases in Human Pluripotent Stem Cells with Base Editors: A Step-by-Step Guide.
Park JC; Kim KT; Jang HK; Cha HJ
Int J Stem Cells; 2023 May; 16(2):234-243. PubMed ID: 36823978
[TBL] [Abstract][Full Text] [Related]
16. A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells.
Wu Y; Zhong A; Sidharta M; Kim TW; Ramirez B; Persily B; Studer L; Zhou T
bioRxiv; 2024 Jan; ():. PubMed ID: 38293122
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic effects of base and prime editing in human hematopoietic stem cells.
Fiumara M; Ferrari S; Omer-Javed A; Beretta S; Albano L; Canarutto D; Varesi A; Gaddoni C; Brombin C; Cugnata F; Zonari E; Naldini MM; Barcella M; Gentner B; Merelli I; Naldini L
Nat Biotechnol; 2024 Jun; 42(6):877-891. PubMed ID: 37679541
[TBL] [Abstract][Full Text] [Related]
18. Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance.
Bowden AR; Morales-Juarez DA; Sczaniecka-Clift M; Agudo MM; Lukashchuk N; Thomas JC; Jackson SP
Elife; 2020 May; 9():. PubMed ID: 32441252
[TBL] [Abstract][Full Text] [Related]
19. Application of the modified cytosine base-editing in the cultured cells of bama minipig.
Pan JS; Lin ZS; Wen JC; Guo JF; Wu XH; Liu YY; Lai WJ; Liang QY; Xie YS; Chen YR; Chen YH; Yan AF; Feng J; Liu L; Gong DY; Zhu XX; Lu JH; Tang DS
Biotechnol Lett; 2021 Sep; 43(9):1699-1714. PubMed ID: 34189671
[TBL] [Abstract][Full Text] [Related]
20. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
